Markets:

Overview

News

Currencies

International

Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

9.885 -0.125 (-1.25%)

Streaming Delayed Price Updated: 3:26 PM EDT, Apr 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance

November 08, 2022

From Bioventus, Inc.

Via GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022

October 31, 2022

From Bioventus, Inc.

Via GlobeNewswire

Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago

October 12, 2022

Full Launch of BoneScalpel® Access™ at NASS

From Bioventus, Inc.

Via GlobeNewswire

Bioventus: Q2 Earnings Insights ↗

August 11, 2022

Bioventus (NASDAQ:BVS) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Bioventus: Q1 Earnings Insights ↗

May 10, 2022

Bioventus (NASDAQ:BVS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Bioventus: Q4 Earnings Insights ↗

March 10, 2022

Bioventus (NASDAQ:BVS) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday ↗

July 14, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

Bioventus's Return On Capital Employed Insights ↗

June 10, 2022

Bioventus (NASDAQ:BVS) brought in sales totaling $117.29 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 682.14%, resulting in a loss of $14.81 million.

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Earnings Scheduled For August 10, 2021 ↗

August 10, 2021

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 04, 2022

On Monday, 78 companies set new 52-week lows. Key Facts About Today's 52-Week Lows: Citigroup (NYSE:C) was the biggest company by market cap to set a new 52-week low....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022 ↗

March 15, 2022

Upgrades For Turquoise Hill Resources Ltd (NYSE:TRQ), BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the...

Via Benzinga

Bioventus Posts Q4 Profit Ahead Of Consensus, Forecasts FY22 Sales Jump Of ~30% ↗

March 10, 2022

Bioventus Inc's (NASDAQ: BVS) Q4 FY21 sales increased 32.3% Y/Y (5.1% organically) to $130.4 million, almost in line with the consensus of $130.3 million. Sales...

Via Benzinga

Bioventus Inc. (BVS) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

BVS earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Will a Powerful Acquisition Make This Early 2021 IPO a Buy? ↗

August 17, 2021

Maybe the equivalent of an extra full quarter of revenue will get the attention of investors.

Via The Motley Fool

Topics Initial Public Offering

Bioventus Inc. (BVS) Q2 2021 Earnings Call Transcript ↗

August 11, 2021

BVS earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Bioventus Scoops Up Misonix In $518M Stock & Cash Deal; Raises FY21 Sales Outlook ↗

July 30, 2021

Recently listed Bioventus Inc (NASDAQ: BVS) has agreed to acquire Misonix Inc (NASDAQ: MSON) for $518 million in a cash-and-stock transaction. Misonix...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021 ↗

July 01, 2021

Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE:

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs ↗

July 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Earnings Scheduled For May 12, 2021 ↗

May 12, 2021

Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.